2016
DOI: 10.7150/thno.14315
|View full text |Cite
|
Sign up to set email alerts
|

Mifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression

Abstract: Triple-negative breast cancer (TNBC) is currently the most malignant subtype of breast cancers without effective targeted therapies. Mifepristone (MIF), a drug regularly used for abortion, has been reported to have anti-tumor activity in multiple hormone-dependent cancers, including luminal type breast cancers. In this study, we showed that MIF suppressed tumor growth of the TNBC cell lines and patient-derived xenografts in NOD-SCID mice. Furthermore, MIF reduced the TNBC cancer stem cell (CSC) population thro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
116
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 109 publications
(118 citation statements)
references
References 53 publications
(72 reference statements)
2
116
0
Order By: Relevance
“…We found that Klf5 is required for PyMT oncogeneinduced mammary gland tumor initiation and development, and contributes to tumor cell stemness, indicating an oncogenic function for Klf5 in mammary tumorigenesis. These results are consistent with our previous findings that KLF5 depletion significantly suppresses breast tumor growth in xenograft mouse models [22,23], and that pharmacological inhibition of KLF5 suppresses breast cancer stem cell self-renewal and maintenance [4]. However, PyMT is not a pathologically relevant carcinogen in humans, so that validating the role of Klf5 in breast tumorigenesis by crossing other pathologically relevant breast cancer mouse models with other Klf5 KO mouse models could be useful.…”
Section: R Liu Et Alsupporting
confidence: 92%
See 2 more Smart Citations
“…We found that Klf5 is required for PyMT oncogeneinduced mammary gland tumor initiation and development, and contributes to tumor cell stemness, indicating an oncogenic function for Klf5 in mammary tumorigenesis. These results are consistent with our previous findings that KLF5 depletion significantly suppresses breast tumor growth in xenograft mouse models [22,23], and that pharmacological inhibition of KLF5 suppresses breast cancer stem cell self-renewal and maintenance [4]. However, PyMT is not a pathologically relevant carcinogen in humans, so that validating the role of Klf5 in breast tumorigenesis by crossing other pathologically relevant breast cancer mouse models with other Klf5 KO mouse models could be useful.…”
Section: R Liu Et Alsupporting
confidence: 92%
“…High expression of KLF5 has been reported to be associated with a worse prognosis and a short survival time in breast cancer patients . Our recent studies found that knockdown of KLF5 suppressed breast tumor growth and breast cancer stem cell maintenance in immune‐knockout mice. We previously reported that KLF5 is induced by progesterone through the progesterone receptor (PR), and Klf5 is highly expressed in mouse mammary glands during pregnancy and lactation .…”
Section: Introductionmentioning
confidence: 84%
See 1 more Smart Citation
“…Thus, circVRK1 was negatively correlated with stemness of BCSCs through the miR-153-5p/krüppel-like factor 5 (KLF5) regulatory pathways. 240 Stem cell plasticity and identity are also controlled by master regulatory genes and complex circuits involving circRNAs as well. One study showed that compared to differentiated mesodermal derivatives, circFOXP1 levels were enriched in mesenchymal stem cell (MSC) and silencing of circFOXP1 dramatically impaired MSC differentiation in vitro and in vivo.…”
Section: Circrnas In Cancer Stem Cellsmentioning
confidence: 99%
“…Breast cancer (BC) is one of the most common malignancies in women, and its incidence is the second highest in the world (1,2).…”
Section: Introductionmentioning
confidence: 99%